Abstract:Brain‐neuronal targeted nanotheranostics with high sensitivity dual‐channel "turn‐on" fluorescence and drug release penetrates the BBB and is specifically located to neurons with AD lesions. By sensing the early AD biomarker ROS, the nanotheranostics (RVG‐NP/NB or RVG‐NP/ONB) exhibits dual‐channel fluorescence "turn‐on" properties and drug release, thereby facilitating both diagnosis and therapy of early AD. Current diagnosis and treatment strategies mainly focus on the pathologies of the mid‐to‐late stage of AD (Alzheimer's disease), with clinical outcomes that are far from ideal. Herein, we developed the ROS (reactive oxygen species)‐responsive brain neuronal targeting nanotheranostic platforms that possess the dual‐channel fluorescent "turn‐on" properties and release drugs in AD neurons in response to ROS, thereby simultaneously facilitating the diagnosis and therapy of early AD. Through the modification of acetylcholine receptor targeting RVG29 peptide, the nanotheranostics penetrated BBB and accumulated into diseased neurons in an intact form, consequently maximizing the diagnostic and therapeutic performance. The anti‐oxidative drug baicalein conjugated onto the surface of nanotheranostics via ROS‐cleavable boronate ester linkage rapidly released for ROS scavenging, while the encapsulated fluorophores turned on their fluorescence for AD diagnosis upon microenvironment stimuli. This nanotheranostic strategy exhibited highly sensitivity with a ROS detection limit of up to 100 μm and accurately early detection of ROS in 3×Tg AD mice at 6 months of age in vivo. In addition, it could also rescue memory defects, scavenge oxidative stress, attenuate neuroinflammation and enhance neuroprotective effect in 3×Tg AD mice. This work opens up a promising and smart strategy for early diagnosis and therapy in neurodegenerative disease.

In Vivo Target Bio-Imaging of Alzheimer's Disease by Fluorescent Zinc Oxide Nanoclusters.

In Vivo Rapid Fluorescence Imaging of Alzheimer’s Disease Through Accurate Target Bio-Marking of Zinc Gluconate

In Vivo Biosynthesized Zinc and Iron Oxide Nanoclusters for High Spatiotemporal Dual-Modality Bioimaging of Alzheimer's Disease.

Fluorescent Gold Nanoclusters for in Vivo Target Imaging of Alzheimer'S Disease

Benzothiazolium Derivative-Capped Silica Nanocomposites for β-Amyloid Imaging In Vivo

In Vivo Target Bio-Imaging of Cerebral Ischemic Stroke by Real-Time Labeling of Zinc

Targeting Zincosomes to Unveil Lysosomal Zinc ion Dynamics and Their Role in Exacerbating Alzheimer's Pathology

In Vivo Brain Imaging of Amyloid-β Aggregates in Alzheimer’s Disease with a Near-Infrared Fluorescent Probe

Diagnosis of Alzheimer's Disease and in Situ Biological Imaging Via an Activatable Near-Infrared Fluorescence Probe.

In Vivo Three-dimensional Brain Imaging with Chemiluminescence Probes in Alzheimer’s Disease Models

An Activatable Near-Infrared Fluorescent Probe with Large Stokes Shift for Visualizing Peroxynitrite in Alzheimer’s Disease Models

Targeted imaging of lysosomal zinc ions with a tetrahedral DNA framework fluorescent reporter

Redox Oxygen Species‐Responsive Nanotheranostics with Dual‐Channel Fluorescent Turn‐On for Early Diagnosis and Targeted Therapy of Alzheimer's Disease

Turn-On NIR-II Polymer Dots with Large Stokes Shift for In Vivo Visualizing Dynamical Brain Zinc in Alzheimer's Disease Mouse

Study of Specially Labeling Amyloid Plaques in Vivo in Alzheimer Transgenic Mice with Targeted Magnetic Nano-Iron Contrast Agent

An activatable near-infrared fluorescent probe with large Stokes shift for visualizing peroxynitrite in Alzheimer's disease models

An Activity-Based Fluorescent Probe for Imaging Fluctuations of Peroxynitrite (ONOO-) in the Alzheimer's Disease Brain.

Ultrasmall Superparamagnetic Iron Oxide Nanoparticles-Bound NIR Dyes: Novel Theranostic Agents for Alzheimer's Disease

Design of an Activatable NIR-II Nanoprobe for the in Vivo Elucidation of Alzheimer's Disease-Related Variations in Methylglyoxal Concentrations.

A Peptide-Based Near-Infrared Fluorescence Probe for Dynamic Monitoring Senile Plaques in Alzheimer's Disease Mouse Model

Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer’s Disease